
U.S. Food and Drug Administration (FDA) employees overseeing Elon Musk's Neuralink clinical trials were abruptly terminated over the weekend as part of a broader government workforce purge, according to a report.
Neuralink's research is highly regulated by the FDA, particularly its Office of Neurological and Physical Medicine Devices, which oversees clinical-trial applications for experimental brain implants, Reuters reported.